News & Updates

Use of either stereotactic body radiotherapy (SBRT) or yttrium-90 (Y90) is effective in the management of hepatocellular carcinoma (HCC), resulting in similar overall and progression-free survival, reports a study. However, Y90 is more expensive than SBRT.

In patients with irritable bowel syndrome (IBS), higher general life satisfaction is associated with higher physical and mental quality of life independently, but not with gastrointestinal (GI) symptom severity, reveals a study.